KRBPQ — Kiromic Biopharma Cashflow Statement
0.000.00%
Last trade - 00:00- $0.09m
- $12.61m
Annual cashflow statement for Kiromic Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -19.2 | -25.6 | -34.7 | -20.9 | -26.9 |
| Depreciation | |||||
| Non-Cash Items | 13.3 | 4.09 | 4.94 | 0.716 | 1.23 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.395 | 0.71 | 4.37 | -3.21 | 3.98 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -6.13 | -20.3 | -23.7 | -21.2 | -19.5 |
| Capital Expenditures | -1.46 | -1.89 | -4.88 | -0.207 | -0.366 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0.084 | 0.015 | — | — |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -1.46 | -1.81 | -4.87 | -0.207 | -0.366 |
| Financing Cash Flow Items | -2.67 | -2.88 | -0.2 | -0.111 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 15.8 | 37.3 | 3.9 | 24 | 18.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 8.22 | 15.2 | -24.7 | 2.56 | -1.41 |